In 2021, the production value of over-the-counter (OTC) drug products in South Korea amounted to around three trillion South Korean won. While this represents a slight decrease from the previous year, production value has generally been increasing overall.
Production value of over-the-counter (OTC) drug products in South Korea from 2010 to 2021 (in trillion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical industry in South Korea
Overview
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2022
- Premium Statistic Pharmaceuticals market size South Korea 2008-2021
- Basic Statistic Pharmaceutical spending as share of GDP South Korea 2000-2022
- Basic Statistic Pharmaceutical spending per capita in South Korea 2000-2022
- Premium Statistic Number of pharmaceutical manufacturers South Korea 2008-2021
Production and distribution
6
- Basic Statistic Pharmaceutical production value South Korea 2010-2021
- Premium Statistic OTC drug products production value South Korea 2010-2021
- Premium Statistic Prescription drug products production value South Korea 2010-2021
- Premium Statistic Leading pharmaceutical products South Korea 2021, by production value
- Premium Statistic Number of pharmaceutical distributors South Korea 2010-2021
- Premium Statistic Number of pharmaceutical distributors South Korea 2021, by type
International trade
6
- Premium Statistic Pharmaceutical export value from South Korea 2012-2021
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2021, by export value
- Premium Statistic Biopharmaceuticals export value from South Korea 2012-2021
- Premium Statistic Pharmaceutical import value in South Korea 2012-2021
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2021, by import value
- Premium Statistic Biopharmaceutical import value in South Korea 2012-2021
Key players
6
- Premium Statistic Leading pharmaceutical businesses South Korea 2022, by revenue
- Premium Statistic Sales revenue Yuhan 2015-2022
- Premium Statistic Revenue of GC Pharma 2015-2022
- Premium Statistic Revenue of Chong Kun Dang 2015-2022
- Premium Statistic Sales revenue Kwang Dong Pharmaceutical 2011-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
OTC pharmaceuticals
5
- Premium Statistic Types of pharmaceutical drugs produced in South Korea 2022, by production value
- Premium Statistic Annual production value of OTC drugs in South Korea 2011-2022
- Premium Statistic Annual import value of OTC drugs in South Korea 2011-2022
- Premium Statistic Types of pharmaceutical drugs imported into South Korea 2022, by import value share
- Premium Statistic Amount of medication supplied to medical facilities South Korea 2022, by supply value
Further related statistics
18
- Genomma Lab: revenue 2013-2018, by region
- Sales revenue from non-prescription drugs Yuhan 2016-2022
- Italy: y-o-y development of OTC revenue 2017-2018, by pharmacy size
- Genomma Lab: revenue 2013-2021
- Sales value of leading brands in the OTC medicine market in Great Britain 2013
- U.S. breakdown of OTC market by major segment 2022 estimates
- Leading OTC hay fever brands in Great Britain 2013, by sales value
- OTC market revenue in Germany by type 2015-2021
- OTC pain relief medicines: breakdown of sales in Great Britain, by category
- OTC medicines: change in sales value in Great Britain 2012-2013, by category
- Leading OTC winter remedy brands in Great Britain 2013, by sales value
- Italy: survey on the awareness of the OTC label 2017
- Over the counter homeopathic and herbal medicine revenue in Germany 2022
- Drug preference among U.S. adults with gastrointestinal problems 2017
- Italy: opinion on self-medication practices in case of small health problems 2017
- Frequency of users of 'Foot Care Products' in GB 2022
- Meiji's pharmaceutical business net sales FY 2013-2022
- Value sales of pain treatments in Great Britain 2017
Further Content: You might find this interesting as well
Statistics
- Genomma Lab: revenue 2013-2018, by region
- Sales revenue from non-prescription drugs Yuhan 2016-2022
- Italy: y-o-y development of OTC revenue 2017-2018, by pharmacy size
- Genomma Lab: revenue 2013-2021
- Sales value of leading brands in the OTC medicine market in Great Britain 2013
- U.S. breakdown of OTC market by major segment 2022 estimates
- Leading OTC hay fever brands in Great Britain 2013, by sales value
- OTC market revenue in Germany by type 2015-2021
- OTC pain relief medicines: breakdown of sales in Great Britain, by category
- OTC medicines: change in sales value in Great Britain 2012-2013, by category
- Leading OTC winter remedy brands in Great Britain 2013, by sales value
- Italy: survey on the awareness of the OTC label 2017
- Over the counter homeopathic and herbal medicine revenue in Germany 2022
- Drug preference among U.S. adults with gastrointestinal problems 2017
- Italy: opinion on self-medication practices in case of small health problems 2017
- Frequency of users of 'Foot Care Products' in GB 2022
- Meiji's pharmaceutical business net sales FY 2013-2022
- Value sales of pain treatments in Great Britain 2017
MFDS (South Korea). (December 29, 2022). Production value of over-the-counter (OTC) drug products in South Korea from 2010 to 2021 (in trillion South Korean won) [Graph]. In Statista. Retrieved December 10, 2023, from https://www.statista.com/statistics/1073826/south-korea-otc-drug-products-production-value/
MFDS (South Korea). "Production value of over-the-counter (OTC) drug products in South Korea from 2010 to 2021 (in trillion South Korean won)." Chart. December 29, 2022. Statista. Accessed December 10, 2023. https://www.statista.com/statistics/1073826/south-korea-otc-drug-products-production-value/
MFDS (South Korea). (2022). Production value of over-the-counter (OTC) drug products in South Korea from 2010 to 2021 (in trillion South Korean won). Statista. Statista Inc.. Accessed: December 10, 2023. https://www.statista.com/statistics/1073826/south-korea-otc-drug-products-production-value/
MFDS (South Korea). "Production Value of Over-the-counter (Otc) Drug Products in South Korea from 2010 to 2021 (in Trillion South Korean Won)." Statista, Statista Inc., 29 Dec 2022, https://www.statista.com/statistics/1073826/south-korea-otc-drug-products-production-value/
MFDS (South Korea), Production value of over-the-counter (OTC) drug products in South Korea from 2010 to 2021 (in trillion South Korean won) Statista, https://www.statista.com/statistics/1073826/south-korea-otc-drug-products-production-value/ (last visited December 10, 2023)
Production value of over-the-counter (OTC) drug products in South Korea from 2010 to 2021 (in trillion South Korean won) [Graph], MFDS (South Korea), December 29, 2022. [Online]. Available: https://www.statista.com/statistics/1073826/south-korea-otc-drug-products-production-value/